Cargando…
MicroRNA‐200a suppresses prostate cancer progression through BRD4/AR signaling pathway
Prostate cancer is still considered a significant health care challenge worldwide due in part to the distinct transformation of androgen‐dependent prostate cancer (ADPC) into treatment‐refractory castration‐resistant prostate cancer (CRPC). Consequently, there is an urgent need to explore novel mole...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488151/ https://www.ncbi.nlm.nih.gov/pubmed/30784214 http://dx.doi.org/10.1002/cam4.2029 |